Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome
- PMID: 33183268
- PMCID: PMC7663882
- DOI: 10.1186/s12884-020-03379-9
Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome
Abstract
Background: Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic condition characterized by capillary hyperpermeability which can be predicted by preovulatory ovarian responses such as number of follicles. A variety of cytokines are thought to be involved in pathophysiology of this syndrome.
Methods: A prospective cohort study invloving sixty intracytoplasmic sperm injection (ICSI) patients. On the day of hCG injection, we explored the threshold of larger follicles ≥11 mm diameter with a count of ≥18 follicles for the high-risk moderate-to-severe OHSS and 13-18 follicles for the low-risk moderate-to-severe OHSS. Whereas larger follicles count of less than 13 were classified as normoresponders. Pooled follicular fluid (FF) samples of each patient were collected on the day of oocyte retrieval. Magnetic multiplex immunoassay was explored to measure the concentrations of some intrafollicular cytokines including: GM-CSF, INF-γ, TNF-α, IL-10, CXCL8/IL-8, IL-6, IL-5, IL-4, IL-2, and IL-1β. All sixty patients underwent controlled ovarian hyperstimulation (COH) with either GnRH agonist or antagonist protocols.
Results: Intrafollicular TNF-α concentration was significantly different (p < 0.05) in the high-risk moderate-to-severe OHSS patients compared to low-risk moderate-to-severe OHSS patients and normoresponders. TNF-α in FF had a negative correlation with the chance of high-risk moderate-to-severe OHSS. The differences in the risk of OHSS between patients who received GnRH agonist or antagonist were not significant (p > 0.05).
Conclusions: In accordance to the negative correlation of TNF-α and high risk of early OHSS, we did not expect TNF-α to play a role in increasing vascular permeability in ovarian tissues. In addition, the risk of early moderate-to-severe OHSS was not affected by different GnRH superovulation protocols.
Keywords: Cytokines; Intracytoplasmic sperm injection; Larger follicles count; Ovarian hyperstimulation syndrome; Tumor necrosis factor- alpha.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.PLoS One. 2016 Mar 7;11(3):e0149615. doi: 10.1371/journal.pone.0149615. eCollection 2016. PLoS One. 2016. PMID: 26950065 Free PMC article.
-
Elevated levels of interleukin-6 in the follicular fluid at the time of oocyte retrieval for in vitro fertilization may predict the development of early-form ovarian hyperstimulation syndrome.Fertil Steril. 1997 Jul;68(1):133-7. doi: 10.1016/s0015-0282(97)81489-6. Fertil Steril. 1997. PMID: 9207598
-
Nomogram model to predict the risk of moderate to severe ovarian hyperstimulation syndrome of long protocol group in fresh cycle.Sci Rep. 2025 Mar 17;15(1):9211. doi: 10.1038/s41598-025-94049-3. Sci Rep. 2025. PMID: 40097634 Free PMC article.
-
The prevention of ovarian hyperstimulation syndrome.J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5. J Obstet Gynaecol Can. 2014. PMID: 25574681 Review. English, French.
-
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.Hum Reprod Update. 1997 May-Jun;3(3):255-66. doi: 10.1093/humupd/3.3.255. Hum Reprod Update. 1997. PMID: 9322101 Review.
Cited by
-
Concentrations of matrix metallopeptidase 9, interleukin 4, and interleukin 8 in follicular fluid, and the results of in vitro fertilization.J Int Med Res. 2022 Sep;50(9):3000605221125641. doi: 10.1177/03000605221125641. J Int Med Res. 2022. PMID: 36138563 Free PMC article.
-
The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review.Metabolites. 2023 Jan 14;13(1):129. doi: 10.3390/metabo13010129. Metabolites. 2023. PMID: 36677054 Free PMC article. Review.
References
-
- Ashrafi M, Bahmanabadi A, Akhond M, Arabipoor A. Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model. Arch Gynecol Obstet. 2015. 10.1007/s00404-015-3723-0. - PubMed
-
- Mathur RS, Severe OHSS. Patients should be allowed to weigh the morbidity of OHSS against benefits of parenthood. Hum Reprod. 1997:2183–5. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources